Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

DRUG: inhaled fluticasone 750 mcg/day twice daily until 2 days without symptoms (maximum 15 consecutive days)

McGill University Health Centre/Research Institute of the McGill University Health Centre